Each year, a singular, powerful purpose draws a dedicated community to the sun-drenched shores of Sailfish Point in Stuart, Florida. It is a gathering defined not by the gravity of the loss that sparked it, but by the momentum of the future it seeks to create. This February, the 14th annual Keith A. Landesman Fundraiser once again brought together friends, family, and philanthropists to honor the memory of a beloved physician while aggressively funding the cutting-edge research that holds the key to curing cancer.
Through a meticulously curated day of activities, an evocative evening program, and the unwavering generosity of a committed donor base, this year’s event raised more than $330,000. These funds are earmarked exclusively for the Cancer Research Institute (CRI) to support the next generation of early-career scientists—the bright minds currently pushing the boundaries of what is possible in the field of cancer immunotherapy.
The Genesis of a Movement: A Family’s Response to Tragedy
To understand the magnitude of this achievement, one must look at the roots of the Keith A. Landesman Memorial Fund. Dr. Keith Landesman was more than a medical professional; he was a husband, a father, and a cardiologist whose life was defined by an innate, quiet compassion. Those who knew him describe him as a man whose primary motivation was the alleviation of suffering in others—a drive that led him into the demanding world of medicine.
Following his untimely passing, his parents, Jane and Richard Landesman, faced a choice that would ripple through the scientific community for over a decade. Rather than retreating into private mourning, the couple chose to transmute their profound grief into a proactive force for change.
The endeavor began modestly years ago, with a golf tournament held at the Birchwood Country Club in Westport, Connecticut. What started as a local tribute among friends and family members steadily evolved into a high-impact philanthropic powerhouse. As the Landesmans relocated their efforts to the Sailfish Point community, the scope and scale of the fundraiser expanded, transforming from a local memorial into a vital pillar of support for national cancer research initiatives. To date, the family’s legacy has raised more than $2.8 million, a testament to the resilience of the human spirit and the power of communal action.
Chronology of Impact: From Golf Course to Scientific Frontier
The history of the Keith A. Landesman Fund is a study in persistence. In its early years, the fundraiser served primarily as a vessel for remembrance, a way for colleagues and friends to process the loss of a man who had dedicated his own career to the health of others.
As the years progressed, the Landesman family realized that the most fitting tribute to a doctor was the advancement of medical science. By aligning their efforts with the Cancer Research Institute, they ensured that every dollar raised would go toward high-impact, high-reward research.
- Phase 1 (The Foundation): Initial small-scale events in Connecticut focused on raising awareness and modest funds, establishing the logistical framework for future growth.
- Phase 2 (The Expansion): The transition to Sailfish Point marked a shift toward a larger, more structured annual gathering, increasing the professional and financial reach of the initiative.
- Phase 3 (The Legacy): With over $2.8 million raised, the fund has moved into a long-term sustainability phase, where the annual event is no longer just a fundraiser, but a recognized institution in the oncology research community.
- Phase 4 (National Recognition): The receipt of the 2025 Oliver R. Grace Award at the CRI Annual Awards Gala solidified the Landesman family’s role as primary architects of modern, donor-supported immunotherapy research.
Investing in the Architects of Tomorrow
A central tenet of the Landesman family’s philosophy is the belief in "fresh eyes." They understand that in science, as in life, breakthrough innovations often come from those who are not yet tethered to the status quo.
The funds raised by the memorial are directed toward CRI postdoctoral fellows—early-career researchers who are often in the most precarious, yet most creative, stage of their professional lives. By providing the financial runway for these scientists to pursue "bold, high-risk, high-reward ideas," the Landesman Fund ensures that the pipeline of discovery remains robust.
"They want to support researchers who are tackling cancer from different angles," says Kevin Landesman, Keith’s brother. "They believe the next breakthrough can come from someone with a new perspective—someone early in their career who just needs the opportunity and support."
For the Cancer Research Institute, this investment is not merely financial; it is strategic. The "discovery pipeline" requires a constant infusion of talent. By supporting scientists at the postdoctoral level, the fund effectively helps secure the future of cancer treatment, ensuring that the next generation of researchers is equipped to tackle the disease with the latest tools in immunotherapy.
Voices of the Frontline: The Human Element
The 14th annual event at Sailfish Point was highlighted by a moving address from Dr. Haydn Kissick, a CRI STAR (Scientist-Targeted Award for Research) and Assistant Professor at the Emory University School of Medicine. Dr. Kissick did not speak as an abstract scientist, but as a person who has walked the same path as the Landesman family. He shared the deeply personal story of his mother’s battle with cancer, a struggle that served as the catalyst for his own career choice.
His vision for the next five years of immunotherapy research provided a beacon of hope for the attendees. When researchers like Dr. Kissick stand before a room of supporters, the abstract goal of "curing cancer" becomes tangible. It bridges the gap between the laboratory and the living room, reminding donors that their contributions are fueling real-world, life-saving work.
"The room is quiet when the speakers are talking," notes Kara Green, Keith’s sister. "Everyone is mesmerized by what’s being discussed. There’s love, there’s some sadness, every emotion is there—but it’s an incredible event."
Institutional Recognition: The Oliver R. Grace Award
The impact of the Landesman family was formally recognized on the national stage at the 2025 CRI Annual Awards Gala, where Jane and Richard Landesman were honored with the Oliver R. Grace Award for Distinguished Service. Named for the founding chairman of the Cancer Research Institute, this award is one of the highest honors in the philanthropic oncology space.
The award recognizes individuals whose dedication to the CRI mission has been both sustained and transformative. For the Landesman family, the award was a humbling moment, though they remain characteristically modest about their achievements.
"They wouldn’t do this for recognition," Kevin Landesman remarked. "They do it because they want to end cancer so other families don’t have to go through what we did."
The gala served as an opportunity for the broader scientific and philanthropic community to thank the Landesmans for their example. It highlighted a crucial reality: the fight against cancer is not only a battle for researchers in white coats, but a collective effort involving families, donors, and advocates who refuse to accept the status quo.
Implications for the Future of Oncology
The implications of the Keith A. Landesman Memorial Fund extend far beyond the $330,000 raised this year. By consistently supporting immunotherapy, the fund is contributing to a paradigm shift in how we treat the disease. Immunotherapy—the practice of training the body’s own immune system to identify and eradicate cancer cells—is widely considered the most promising frontier in oncology.
The sustained, long-term nature of the Landesmans’ commitment provides the financial stability that scientists need to engage in longitudinal studies. Unlike short-term grants that require immediate results, the funding provided through the CRI fellowship program allows for the kind of deep, iterative exploration that leads to genuine medical breakthroughs.
A Legacy That Grows with Time
Behind every successful event is an untold story of labor. For the Landesmans, the cycle of giving never truly pauses. As soon as the sun sets on the annual fundraiser, the planning for the next year begins. This level of dedication is what has allowed the event to grow larger and more impactful with each iteration.
"My parents work on it all year long," says Kara Green. "Every event somehow becomes bigger than the last."
As the Keith A. Landesman Memorial Fund moves into its next decade, it stands as a testament to the idea that even the most profound personal loss can be channeled into a force for global good. Through their work, the Landesman family is not only honoring a beloved brother, husband, and father; they are providing the fuel for a scientific revolution that could, one day, relegate cancer to a historical footnote.
As Kevin Landesman reflects on the journey so far, his words carry the weight of both memory and hope: "I think he would be unbelievably proud that his legacy lives on through these events."
In the quiet rooms of research laboratories across the country, where young scientists are working to unlock the mysteries of the immune system, the legacy of Dr. Keith Landesman is already at work—saving lives, one discovery at a time.
